A prospective comparison of duplex ultrasonography, captopril renography, MRA, and CTA in assessing renal artery stenosis. 2006

H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
Department of Radiology, Uppsala University Hospital, Uppsala, Sweden. hampus.eklof@radiol.uu.se

OBJECTIVE To prospectively compare the diagnostic accuracy of duplex ultrasonography, captopril renography, computed tomography angiography (CTA), and 3D Gd magnetic resonance angiography (MRA) in diagnosing hemodynamically significant renal artery stenosis (RAS). METHODS The standard of reference was measurement of transstenotic pressure gradient. Fifty-eight hypertensive patients with suspicion of RAS were evaluated, when possible, by all five techniques. Sensitivity and specificity to detect RAS were compared for each technique on both a patient and kidney basis. Discrepancies were evaluated separately and classified as borderline, method dependent, or operator dependent. RESULTS The prevalence of RAS was 77%. The sensitivity/specificity of ultrasonography, captopril renography, CTA, and MRA in detecting kidneys with RAS was 73/71%, 52/63%, 94/62%, and 93/91%, respectively. Ultrasonography had a significantly lower sensitivity than CTA and MRA (P<0.001) but higher than captopril renography (P = 0.013). Borderline RAS was the main cause for discrepancies. CONCLUSIONS MRA and CTA were significantly better than duplex ultrasonography and captopril renography in detecting hemodynamically significant RAS. The ultrasonography criteria for RAS based on the evaluation of renal peak systolic velocity and renal/aortic ratio are questionable. Captopril renography cannot be recommended for assessing RAS.

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011446 Prospective Studies Observation of a population for a sufficient number of persons over a sufficient number of years to generate incidence or mortality rates subsequent to the selection of the study group. Prospective Study,Studies, Prospective,Study, Prospective
D011866 Radioisotope Renography Graphic tracing over a time period of radioactivity measured externally over the kidneys following intravenous injection of a radionuclide which is taken up and excreted by the kidneys. Renography,Radioisotope Renographies,Renographies,Renographies, Radioisotope,Renography, Radioisotope
D012078 Renal Artery Obstruction Narrowing or occlusion of the RENAL ARTERY or arteries. It is due usually to ATHEROSCLEROSIS; FIBROMUSCULAR DYSPLASIA; THROMBOSIS; EMBOLISM, or external pressure. The reduced renal perfusion can lead to renovascular hypertension (HYPERTENSION, RENOVASCULAR). Renal Artery Stenosis,Obstruction, Renal Artery,Obstructions, Renal Artery,Renal Artery Obstructions,Renal Artery Stenoses,Stenoses, Renal Artery,Stenosis, Renal Artery
D002216 Captopril A potent and specific inhibitor of PEPTIDYL-DIPEPTIDASE A. It blocks the conversion of ANGIOTENSIN I to ANGIOTENSIN II, a vasoconstrictor and important regulator of arterial blood pressure. Captopril acts to suppress the RENIN-ANGIOTENSIN SYSTEM and inhibits pressure responses to exogenous angiotensin. (S)-1-(3-Mercapto-2-methyl-1-oxopropyl)-L-proline,Capoten,Lopirin,SQ-14,225,SQ-14,534,SQ-14225,SQ-14534,SQ 14,225,SQ 14,534,SQ 14225,SQ 14534,SQ14,225,SQ14,534,SQ14225,SQ14534
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
August 2000, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
February 1992, Journal of nuclear medicine : official publication, Society of Nuclear Medicine,
H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
August 2004, Pediatric radiology,
H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
September 1991, Hypertension (Dallas, Tex. : 1979),
H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
December 1991, American journal of hypertension,
H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
November 2017, Clinical nuclear medicine,
H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
September 2005, European journal of nuclear medicine and molecular imaging,
H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
February 1994, Journal of vascular surgery,
H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
January 1991, The American journal of medicine,
H Eklöf, and H Ahlström, and A Magnusson, and L-G Andersson, and B Andrén, and A Hägg, and D Bergqvist, and R Nyman
July 1999, Clinical nuclear medicine,
Copied contents to your clipboard!